Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SynerFuse logo — company profile

SynerFuse

Founded 2015 United States Minneapolis, United States 9 employees

General Information

Company Name SynerFuse
Founded Year 2015
Location United States Minneapolis, United States +1
Employees 9
Social

Get notified when SynerFuse moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SynerFuse

CAUTION -– Investigational device. Limited by Federal (or United States) law to investigational use. SynerFuse is long-term pain management without the use of addictive opioids. SynerFuse combines two FDA-approved technologies and synergistically fuses both in order to attack the problem of long-term, post-surgery, lower back pain, with a preemptive, drug-free pain management system.

No funding data available for SynerFuse yet.

Get notified when SynerFuse raises funding

SynerFuse Alternatives & Competitors

SynerFuse vs
GlySens Incorporated
GlySens Incorporated United States

At GlySens®, we are dedicated to advancing the care of individuals with diabetes through the develop...

Series D
5 employees
Health Care, Manufacturing
SynerFuse vs
Amber Implants BV
Amber Implants BV The Netherlands

Improving the quality of life of the global aging population

Series A
18 employees
Health Care, Manufacturing
SynerFuse vs
OrthoSpace - Acquired by Stryker (NYSE:SYE)
OrthoSpace - Acquired by Stryker (NYSE:SYE) Israel

Orthospace Ltd develops and commercializes simple-to-implant, biodegradable balloon systems for the...

Series Unknown
14 employees
Biotechnology, Medical Devices

FAQ About SynerFuse

CAUTION -– Investigational device. Limited by Federal (or United States) law to investigational use. SynerFuse is long-term pain management without the use of addictive opioids. SynerFuse combines two FDA-approved technologies and synergistically fuses both in order to attack the problem of long-te...
SynerFuse was founded in 2015.
SynerFuse is headquartered in Minneapolis, United States.
SynerFuse has approximately 9 employees.
Top alternatives and competitors to SynerFuse include GlySens Incorporated, Amber Implants BV, OrthoSpace - Acquired by Stryker (NYSE:SYE), New Sans Souci Nursing Home, Nextgen Pain & Injury Clinic. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SynerFuse and GlySens Incorporated are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SynerFuse and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy